Your cart is empty
Start Shopping$99.00
This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.
Research Summary | Description |
---|---|
Protective effects of BPC 157 on liver, kidney, and lung distant organ damage in rats with experimental lower-extremity ischemia–reperfusion injury |
Summary: This study on rats investigated the protective effects of BPC 157 against remote organ damage (liver, kidneys, and lungs) following a lower extremity ischemia-reperfusion injury. The findings demonstrated that BPC 157 significantly protected these distant organs by mitigating oxidative stress and reducing inflammation. Citation: Budiša, A. V., Bilandžija, A. T., Vranješ, D., Vukojević, J., Tufan, M., Seiwerth, S., Sikiric, P. (2025). Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury. Medicina, 61(2), 291. |
Multifunctionality and possible medical application of the BPC 157 peptide—literature and patent review |
Summary: This comprehensive review summarizes the biological activities and potential medical applications of BPC 157, based on existing literature and patents. It discusses the peptide's pleiotropic effects, including its role in tissue injury, inflammatory bowel disease, and central nervous system disorders, while also addressing its safety profile and the lack of human clinical trials. Citation: Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185. |
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs |
Summary: This preclinical study investigated the pharmacokinetics of BPC 157 in rats and dogs. It provides data on the peptide's absorption, distribution, metabolism, and excretion, which are essential for its potential future clinical development. The study found that BPC 157 has linear pharmacokinetic characteristics and is rapidly metabolized in vivo. Citation: He, D., Hu, H., Cai, X., Xue, W., Shen, W., & Han, J. (2022). Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Drug Design, Development and Therapy, 16, 4193–4204. |
Stable gastric pentadecapeptide BPC 157 and wound healing |
Summary: This article explores the role of BPC 157 in wound healing. It highlights the peptide's ability to promote angiogenesis and its cytoprotective properties, which contribute to its effectiveness in repairing various types of wounds, including those in the gastrointestinal tract, skin, and tendons. Citation: Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Rokotov, D., Brcic, I., ... & Petek, M. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 628920. |
Utilizing developmentally essential secreted peptides such as thymosin beta-4 to remind the adult organs of their embryonic state—new directions in anti-aging regenerative therapies |
Summary: This review discusses the regenerative potential of Thymosin Beta-4 (the parent molecule of TB 500) and its ability to reactivate embryonic processes in adult tissues. It highlights the peptide's role in tissue repair, specifically mentioning its use in injured or infected eyes and in dermal wound healing. Citation: Maar, K., Aichler, M., & Walz, M. (2021). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies. Frontiers in Cell and Developmental Biology, 9, 660851. |
BPC 157: An emerging therapeutic agent for neuroprotection and regeneration |
Summary: This review focuses on the neuroprotective and regenerative effects of BPC 157. It summarizes the peptide's beneficial effects in various preclinical models of central nervous system (CNS) disorders, including its ability to counteract brain damage and improve functional recovery after stroke. Citation: Vukojević, J., Kolenc, D., Brcic, I., & Seiwerth, S. (2020). BPC 157: An Emerging Therapeutic Agent for Neuroprotection and Regeneration. Neural Regeneration Research, 15(11), 2097-2104. |
Reawakening the regenerative potential of the heart with thymosin beta 4: A new strategy for cardiac repair |
Summary: This article explores the therapeutic potential of Thymosin Beta 4 (TB4) in cardiac repair. It discusses how TB4 can promote the regeneration of heart tissue and improve cardiac function after a myocardial infarction (heart attack) by stimulating the proliferation and migration of cardiovascular cells. Citation: Smart, N., & Venter, D. J. (2020). Reawakening the Regenerative Potential of the Heart with Thymosin Beta 4: A New Strategy for Cardiac Repair. Current Heart Failure Reports, 17(2), 108–114. |
Thymosin beta 4 and the eye: a review of basic and clinical studies |
Summary: This comprehensive review examines the role of Thymosin Beta 4 (TB4) in the eye, drawing from both basic science and clinical studies. It highlights the peptide's ability to promote corneal wound healing, reduce inflammation, and protect against various ocular diseases, suggesting its potential as a therapeutic agent for eye conditions. Citation: Sosne, G., & Djalilian, A. R. (2020). Thymosin Beta 4 and the eye: a review of basic and clinical studies. Experimental Biology and Medicine, 245(15), 1417–1425. |
Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair |
Summary: TB500, like its parent Tβ4, possesses anti-inflammatory abilities. It helps reduce swelling, redness, and pain associated with injuries by controlling the inflammatory response. Citation: Siam Clinic Thailand. (n.d.). Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair. |
Local and systemic peptide therapies for soft tissue regeneration: a narrative review |
Summary: This review identified various peptides, including those related to TB500, demonstrating efficacy in soft tissue repair. It noted that oral and intra-articular peptides showed distinct advantages in soft tissue regeneration, with intra-articular routes providing localized effects and oral routes offering systemic benefits. Citation: Canapp Jr, S. O., Leasure, C. S., & Canapp, D. A. (2024). Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Cells, 13(18), 1545. |
Summary: This study on rats investigated the protective effects of BPC 157 against remote organ damage (liver, kidneys, and lungs) following a lower extremity ischemia-reperfusion injury. The findings demonstrated that BPC 157 significantly protected these distant organs by mitigating oxidative stress and reducing inflammation.
Citation: Budiša, A. V., Bilandžija, A. T., Vranješ, D., Vukojević, J., Tufan, M., Seiwerth, S., Sikiric, P. (2025). Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury. Medicina, 61(2), 291.
Summary: This comprehensive review summarizes the biological activities and potential medical applications of BPC 157, based on existing literature and patents. It discusses the peptide's pleiotropic effects, including its role in tissue injury, inflammatory bowel disease, and central nervous system disorders, while also addressing its safety profile and the lack of human clinical trials.
Citation: Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185.
Summary: This preclinical study investigated the pharmacokinetics of BPC 157 in rats and dogs. It provides data on the peptide's absorption, distribution, metabolism, and excretion, which are essential for its potential future clinical development. The study found that BPC 157 has linear pharmacokinetic characteristics and is rapidly metabolized in vivo.
Citation: He, D., Hu, H., Cai, X., Xue, W., Shen, W., & Han, J. (2022). Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Drug Design, Development and Therapy, 16, 4193–4204.
Summary: This article explores the role of BPC 157 in wound healing. It highlights the peptide's ability to promote angiogenesis and its cytoprotective properties, which contribute to its effectiveness in repairing various types of wounds, including those in the gastrointestinal tract, skin, and tendons.
Citation: Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Rokotov, D., Brcic, I., ... & Petek, M. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 628920.
Summary: This review discusses the regenerative potential of Thymosin Beta-4 (the parent molecule of TB 500) and its ability to reactivate embryonic processes in adult tissues. It highlights the peptide's role in tissue repair, specifically mentioning its use in injured or infected eyes and in dermal wound healing.
Citation: Maar, K., Aichler, M., & Walz, M. (2021). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies. Frontiers in Cell and Developmental Biology, 9, 660851.
Summary: This review focuses on the neuroprotective and regenerative effects of BPC 157. It summarizes the peptide's beneficial effects in various preclinical models of central nervous system (CNS) disorders, including its ability to counteract brain damage and improve functional recovery after stroke.
Citation: Vukojević, J., Kolenc, D., Brcic, I., & Seiwerth, S. (2020). BPC 157: An Emerging Therapeutic Agent for Neuroprotection and Regeneration. Neural Regeneration Research, 15(11), 2097-2104.
Summary: This article explores the therapeutic potential of Thymosin Beta 4 (TB4) in cardiac repair. It discusses how TB4 can promote the regeneration of heart tissue and improve cardiac function after a myocardial infarction (heart attack) by stimulating the proliferation and migration of cardiovascular cells.
Citation: Smart, N., & Venter, D. J. (2020). Reawakening the Regenerative Potential of the Heart with Thymosin Beta 4: A New Strategy for Cardiac Repair. Current Heart Failure Reports, 17(2), 108–114.
Summary: This comprehensive review examines the role of Thymosin Beta 4 (TB4) in the eye, drawing from both basic science and clinical studies. It highlights the peptide's ability to promote corneal wound healing, reduce inflammation, and protect against various ocular diseases, suggesting its potential as a therapeutic agent for eye conditions.
Citation: Sosne, G., & Djalilian, A. R. (2020). Thymosin Beta 4 and the eye: a review of basic and clinical studies. Experimental Biology and Medicine, 245(15), 1417–1425.
Summary: TB500, like its parent Tβ4, possesses anti-inflammatory abilities. It helps reduce swelling, redness, and pain associated with injuries by controlling the inflammatory response.
Citation: Siam Clinic Thailand. (n.d.). Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair.
Summary: This review identified various peptides, including those related to TB500, demonstrating efficacy in soft tissue repair. It noted that oral and intra-articular peptides showed distinct advantages in soft tissue regeneration, with intra-articular routes providing localized effects and oral routes offering systemic benefits.
Citation: Canapp Jr, S. O., Leasure, C. S., & Canapp, D. A. (2024). Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Cells, 13(18), 1545.
Your cart is empty
Start Shopping